Synnovation Therapeutics announced it raised $25 Million in an initial filing from an offering of $25 Million

Company

Location

About

Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. We are dedicated to the discovery and development of first-in-class and best-in-class therapeutics that can improve the lives of people with cancer. Leveraging our deep expertise in medicinal chemistry, cancer biology and patient-focused precision medicine, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.